Abstract
Novel Quality Control Metric for the Pharmacotherapy of Major Depressive Disorder: Measuring Guideline Concordance and Its Impact on Symptom Severity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have